List of Tables
Table 1. Global Cholesterol Lowering Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Cholesterol Lowering Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Cholesterol Lowering Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Cholesterol Lowering Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Cholesterol Lowering Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Cholesterol Lowering Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Cholesterol Lowering Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Cholesterol Lowering Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Cholesterol Lowering Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Cholesterol Lowering Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Cholesterol Lowering Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Cholesterol Lowering Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cholesterol Lowering Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cholesterol Lowering Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cholesterol Lowering Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Cholesterol Lowering Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Cholesterol Lowering Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Cholesterol Lowering Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Cholesterol Lowering Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Cholesterol Lowering Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Cholesterol Lowering Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Cholesterol Lowering Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Cholesterol Lowering Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Cholesterol Lowering Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Cholesterol Lowering Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Cholesterol Lowering Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Cholesterol Lowering Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Cholesterol Lowering Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Cholesterol Lowering Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Cholesterol Lowering Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Cholesterol Lowering Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Cholesterol Lowering Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Cholesterol Lowering Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Cholesterol Lowering Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Cholesterol Lowering Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Cholesterol Lowering Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Cholesterol Lowering Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Cholesterol Lowering Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Cholesterol Lowering Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Cholesterol Lowering Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Cholesterol Lowering Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Cholesterol Lowering Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Cholesterol Lowering Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Cholesterol Lowering Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Cholesterol Lowering Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Cholesterol Lowering Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Cholesterol Lowering Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Cholesterol Lowering Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Cholesterol Lowering Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Cholesterol Lowering Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Cholesterol Lowering Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Cholesterol Lowering Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Cholesterol Lowering Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Cholesterol Lowering Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Cholesterol Lowering Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Cholesterol Lowering Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Cholesterol Lowering Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Cholesterol Lowering Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Cholesterol Lowering Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Cholesterol Lowering Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Cholesterol Lowering Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Cholesterol Lowering Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Cholesterol Lowering Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Cholesterol Lowering Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Cholesterol Lowering Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Cholesterol Lowering Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Cholesterol Lowering Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Cholesterol Lowering Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Cholesterol Lowering Drugs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Novartis Cholesterol Lowering Drugs Product
Table 79. Novartis Recent Developments/Updates
Table 80. Kowa Pharmaceuticals Company Information
Table 81. Kowa Pharmaceuticals Description and Business Overview
Table 82. Kowa Pharmaceuticals Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Kowa Pharmaceuticals Cholesterol Lowering Drugs Product
Table 84. Kowa Pharmaceuticals Recent Developments/Updates
Table 85. Medicure Pharma Company Information
Table 86. Medicure Pharma Description and Business Overview
Table 87. Medicure Pharma Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Medicure Pharma Cholesterol Lowering Drugs Product
Table 89. Medicure Pharma Recent Developments/Updates
Table 90. Merck Company Information
Table 91. Merck Description and Business Overview
Table 92. Merck Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Merck Cholesterol Lowering Drugs Product
Table 94. Merck Recent Developments/Updates
Table 95. Sanofi Company Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Sanofi Cholesterol Lowering Drugs Product
Table 99. Sanofi Recent Developments/Updates
Table 100. Regeneron Pharmaceuticals Company Information
Table 101. Regeneron Pharmaceuticals Description and Business Overview
Table 102. Regeneron Pharmaceuticals Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Regeneron Pharmaceuticals Cholesterol Lowering Drugs Product
Table 104. Regeneron Pharmaceuticals Recent Developments/Updates
Table 105. Amgen Company Information
Table 106. Amgen Description and Business Overview
Table 107. Amgen Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Amgen Cholesterol Lowering Drugs Product
Table 109. Amgen Recent Developments/Updates
Table 110. Innovent Biologics Company Information
Table 111. Innovent Biologics Description and Business Overview
Table 112. Innovent Biologics Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Innovent Biologics Cholesterol Lowering Drugs Product
Table 114. Innovent Biologics Recent Developments/Updates
Table 115. Viatris Company Information
Table 116. Viatris Description and Business Overview
Table 117. Viatris Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Viatris Cholesterol Lowering Drugs Product
Table 119. Viatris Recent Developments/Updates
Table 120. Hisun Pharmaceutical Company Information
Table 121. Hisun Pharmaceutical Description and Business Overview
Table 122. Hisun Pharmaceutical Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Hisun Pharmaceutical Cholesterol Lowering Drugs Product
Table 124. Hisun Pharmaceutical Recent Developments/Updates
Table 125. Esperion Therapeutics Company Information
Table 126. Esperion Therapeutics Description and Business Overview
Table 127. Esperion Therapeutics Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Esperion Therapeutics Cholesterol Lowering Drugs Product
Table 129. Esperion Therapeutics Recent Developments/Updates
Table 130. Otsuka Pharmaceutical Company Information
Table 131. Otsuka Pharmaceutical Description and Business Overview
Table 132. Otsuka Pharmaceutical Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Otsuka Pharmaceutical Cholesterol Lowering Drugs Product
Table 134. Otsuka Pharmaceutical Recent Developments/Updates
Table 135. Cheplapharm Arzneimittel Company Information
Table 136. Cheplapharm Arzneimittel Description and Business Overview
Table 137. Cheplapharm Arzneimittel Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Cheplapharm Arzneimittel Cholesterol Lowering Drugs Product
Table 139. Cheplapharm Arzneimittel Recent Developments/Updates
Table 140. Cosette Pharmaceuticals Company Information
Table 141. Cosette Pharmaceuticals Description and Business Overview
Table 142. Cosette Pharmaceuticals Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Cosette Pharmaceuticals Cholesterol Lowering Drugs Product
Table 144. Cosette Pharmaceuticals Recent Developments/Updates
Table 145. Teva Company Information
Table 146. Teva Description and Business Overview
Table 147. Teva Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Teva Cholesterol Lowering Drugs Product
Table 149. Teva Recent Developments/Updates
Table 150. Akeso Company Information
Table 151. Akeso Description and Business Overview
Table 152. Akeso Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Akeso Cholesterol Lowering Drugs Product
Table 154. Akeso Recent Developments/Updates
Table 155. Glenmark Company Information
Table 156. Glenmark Description and Business Overview
Table 157. Glenmark Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Glenmark Cholesterol Lowering Drugs Product
Table 159. Glenmark Recent Developments/Updates
Table 160. Zydus Company Information
Table 161. Zydus Description and Business Overview
Table 162. Zydus Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Zydus Cholesterol Lowering Drugs Product
Table 164. Zydus Recent Developments/Updates
Table 165. Apotex Company Information
Table 166. Apotex Description and Business Overview
Table 167. Apotex Cholesterol Lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Apotex Cholesterol Lowering Drugs Product
Table 169. Apotex Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Cholesterol Lowering Drugs Distributors List
Table 173. Cholesterol Lowering Drugs Customers List
Table 174. Cholesterol Lowering Drugs Market Trends
Table 175. Cholesterol Lowering Drugs Market Drivers
Table 176. Cholesterol Lowering Drugs Market Challenges
Table 177. Cholesterol Lowering Drugs Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cholesterol Lowering Drugs
Figure 2. Global Cholesterol Lowering Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Cholesterol Lowering Drugs Market Share by Type: 2025 & 2032
Figure 4. Statins Product Picture
Figure 5. Cholesterol Absorption Inhibitors Product Picture
Figure 6. PCSK9 Inhibitors Product Picture
Figure 7. Cholesterol Chelators Product Picture
Figure 8. Others Product Picture
Figure 9. Global Cholesterol Lowering Drugs Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Cholesterol Lowering Drugs Market Share by Application: 2025 & 2032
Figure 11. Hospital Pharmacy
Figure 12. Retail Pharmacy
Figure 13. Online Pharmacy
Figure 14. Global Cholesterol Lowering Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Cholesterol Lowering Drugs Market Size (US$ Million), 2021–2032
Figure 16. Global Cholesterol Lowering Drugs Sales (K Units), 2021–2032
Figure 17. Global Cholesterol Lowering Drugs Average Price (US$/Unit), 2021–2032
Figure 18. Cholesterol Lowering Drugs Report Years Considered
Figure 19. Cholesterol Lowering Drugs Sales Share by Manufacturers in 2025
Figure 20. Global Cholesterol Lowering Drugs Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Cholesterol Lowering Drugs Players: Market Share by Revenue in Cholesterol Lowering Drugs in 2025
Figure 22. Cholesterol Lowering Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Cholesterol Lowering Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Cholesterol Lowering Drugs Sales Market Share by Country (2021–2032)
Figure 25. North America Cholesterol Lowering Drugs Revenue Market Share by Country (2021–2032)
Figure 26. United States Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Cholesterol Lowering Drugs Sales Market Share by Country (2021–2032)
Figure 29. Europe Cholesterol Lowering Drugs Revenue Market Share by Country (2021–2032)
Figure 30. Germany Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Cholesterol Lowering Drugs Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Cholesterol Lowering Drugs Revenue Market Share by Region (2021–2032)
Figure 37. China Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Cholesterol Lowering Drugs Sales Market Share by Country (2021–2032)
Figure 45. Latin America Cholesterol Lowering Drugs Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Cholesterol Lowering Drugs Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Cholesterol Lowering Drugs Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Cholesterol Lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Cholesterol Lowering Drugs by Type (2021–2032)
Figure 56. Global Revenue Market Share of Cholesterol Lowering Drugs by Type (2021–2032)
Figure 57. Global Cholesterol Lowering Drugs Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Cholesterol Lowering Drugs by Application (2021–2032)
Figure 59. Global Revenue Market Share of Cholesterol Lowering Drugs by Application (2021–2032)
Figure 60. Global Cholesterol Lowering Drugs Price (US$/Unit) by Application (2021–2032)
Figure 61. Cholesterol Lowering Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
